Diarect有着20多年自身抗原研发经验的Liedvogel教授和Hanbruck博士联手创建。1993年Haubruck博士利用杆状病毒/Sf9昆虫细胞表达系统成功的研发出人重组抗原--TPO，6年后Diarect是第一家将人重组TPO引进体外诊断市场的公司。

Established in 1998, DIARECT AG is a privately owned biotech company with expertise in developing and establishing standardized large-scale productions of both recombinant and native proteins, including their worldwide distribution. Providing customers with products and services of consistent quality is one of the cornerstones of DIARECT’s business philosophy.

DIARECT is not only a leading manufacturer of autoimmune and infectious disease antigens, but also of recombinant allergens. In additon, DIARECT is the exclusive distributor of Surmodics in Europe. With Surmodics' protein stabilization reagents, blockers and BioFX substrates, DIARECT is able to provide most of the critical components for the development of diagnostic end products.

Diarect公司的主要产品包括：

Allergens

Autoimmune Disease Antigens

Infectious Disease Antigens

Antigen FAQ

Selected References

Protein Stabilizers / Blockers

Immunoassay Stabilizers

Protein and Conjugate Stabilizers

Microsphere and Microarray Stabilizers

StabilBlot™ Blockers

Protein Stabilizers / Blockers FAQ

Selected References

Immunoassay Substrates

更多详情请联系 

维百奥（北京）生物科技有限公司

全国服务热线：400-001-2615

邮箱：info@vicbio.com

网站：www.vicbio.com